Formas farmacêuticas semi-sólidas de uso tópico contendo ... - UFRJ

SHCHIPUNOV YA, SHUMILINA EV. Lecithin organogels: role of polar solvent andnature of intermolecular interactions. Colloid J.v.58, p.117-125, 1996.SHUMILINA EV, KHROMOVA Y, SHCHIPUNOV YA. Lecithin organogels: the effect ofphosphatidylethanolamine additives. Colloid J.1997;59:514-518.SIEWERT,M.; DRESSMAN, J.; BROWN, C.K.; SHAH, V.P. FIP/AAPS: Guidelines toDissolution / in vitro Release Testing of Novel / Special Dodage Forms. AAPSPharmSciTech. V.4 (1), article 7, 2003.SILVA, C.L. et al. Stratum corneum hydration: Phase trasformations and mobility instratum corneum, extracted lipids and isolated corneocytes. Biochimica et BiophysicaActa, 2007SINKO, J.P., Martin: físico-farmácia e ciências farmacêuticas. São Paulo: EditoraArtmed, 2008, 809 p.SINGH, S.; SINGH, J. Transdermal drug deliveri by passive diffusion and iontophoresis:a review. Med. Res. Rev., New York, v.13, n.5, p.569-621, 1993.SORKIN, E.M.; CLISSOLD, S.P.; BROGDEN, R.N. Nifedipine. A review of thispharmaconynamic and pharmacikinetics properties and therapeutic efficacy, inischaemic heart disease, hipertension and related cardiovascular disorders. Drugs, v.30,p. 182-274, 1985.SQUILLANTE, E. et.al. Optimization of in vitro nofedipine penetration enhancementthough hairless mouse skin. Int. J. Pharm. V.169, p.143-154, 1998.SUBER, C. et. al. Optimization of topical therapy: partitioning of drug into stratumcorneum. Pharm. Res., New York, v.7, n.12, p. 1320-1324, 1990.TORSIELLO, M.J.; KOPACKI, M.H. Transdermal Nifedipine for wound healing: casereports. Int. J. Pharm. Compounding, v.4, n.5, p.356-358, 2000TURAKKA, L.; ALA-FOSSI, N. Influence of propylene glycol on the release ofhidrocortisone and its acetate ester from carbopol hydrogel. Acta Pharm. Fennica, v.96,p.15-21, 1987.156